ACS To open Key Positions To Competition In Massive “Reorganization for the ‘90’s
In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia
New ACS Structure Proposed, approved
Seffrin; First Year ACS Shows “Simple Problems Aren’t”
Diet Supplements Should Be Held To Scientific Standards, Broder Tells House
NCI Awards Regional CIS Contracts
FDA Encourages Study Of Gender Differences
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Anthony Letai pledges to ensure stability for extramural and intramural cancer science









